期刊文献+

噬血细胞性淋巴组织细胞增多症的研究现状及治疗进展 被引量:1

原文传递
导出
摘要 噬血细胞性淋巴组织细胞增多症(HLH)又称为噬血细胞综合征(HPS)。它是一组由于各种致病因素导致淋巴细胞和组织细胞反应性增生,释放大量炎性细胞因子,从而损伤重要脏器功能的疾病。目前诊断该病主要依靠国际组织细胞协会制定的HLH-2004诊断指南。2009年美国血液学会义对该诊断指南进行了更新修改。本病临床表现复杂多样,多见持续发热、脾大、全血细胞减少、血清铁蛋白升高、高甘油三酯血症、低纤维蛋白原血症及神经系统症状等。目前提倡应用依托泊苷、环孢素A及地塞米松等免疫化疗药物治疗,异基凶造血干细胞移植也是治疗HLH的有效方法之一。本文对该病近年的研究现状和治疗进展进行简要阐述。
出处 《国际输血及血液学杂志》 CAS 2011年第4期328-332,共5页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献28

  • 1Henter JI, Horne A, Aric6 M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007, 48 (2) : 124-131.
  • 2Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet, 1999, 64(1) :165-171.
  • 3Stepp SE, Dufourcq-Lagelouse R, Ire Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 1999, 286(5446) :1957-1959.
  • 4Feldmann J, Callebaut I, Raposo G, et al. Muncl3-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell, 2003, 115 (4) :461-473.
  • 5Aktas E, Kucuksezer UC, Bilgic S, et al. Relationship between CD107a expression and cytotoxic activity. Cell Immunol, 2009, 254(2) : 149-154.
  • 6Marcenaro S, Gallo F, Martini S, et al. Analysis of nature killer-cell function in familial hemophagocytic lymphohistiocytosis(FHL):defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood, 2006, 108(7):2316-2323.
  • 7zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytie lymphohistiocytosis ( FHL ) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet, 2005, 14(6) :827-834.
  • 8Cote M, Menager MM, Burgess A, et al. Munc18-2 deficiency causes familial hemophagocytie lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest, 2009, 119(12) :3765-3773.
  • 9Kaplan J, De Domenico I, Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol, 2008,15 (1) : 22-29.
  • 10Janka GE. Familial and acquired hemophagocytic lymphohis- tiocytosis. EurJPediatr, 2007, 166(2) :95-109.

二级参考文献11

  • 1Henter JI, Home A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytie lymphohistiocytosis. Pedi- atr Blood Cancer, 2007 ; 48 (2) : 124 - 131.
  • 2Shin HJ, Chung JS, Lee JJ, et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagoeytic lymphohistiocy- tosis. J Korean Med Sci, 2008; 23 (3) : 439 -444.
  • 3Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytie lymphohistiocytosis. Am J He- matol, 2006; 81 (1) : 59 -61.
  • 4Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daelizumab in an adult patient with hemophago- cytic lymphohistiocytosis. Am J Hematol, 2008 ; 83 (9) : 747 - 749.
  • 5Imashuku S. Clinical features and treatment strategies of Epstein- Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol, 2002 ; 44 (3) :259 - 272.
  • 6Maakaroun NR, Moanna A, Jacob JT, et al. Viral infections associ- ated with haemophagocytic syndrome. Rev Med Virol, 2010; 20 (2) :93 - 105.
  • 7Imashuku S, Tabata Y, Teramura T, et al. Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma, 2000 ; 39 ( 1 - 2) :37 - 49.
  • 8Imashuku S, Kuriyama K, Teramura T, et al. Requirement for eto- poside in the treatment of Epstein-Barr virus-associated hemophago- cytie lymphohistiocytosis. J Clin Oncol, 2001 ; 19(10) :2665 -2673.
  • 9Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemopha- gocytic lymphohistiocytosis in Japan. Int J Hematol, 2007 ; 86 ( 1 ) : 58 - 65.
  • 10Baker KS, Filipovich AH, Gross TG, et al. Unrelated donor hemato- poietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant, 2008; 42(3) :175 - 180.

共引文献1

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部